Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ibex (IBEX) Cash & Equivalents (2019 - 2025)

Ibex (IBEX) has disclosed Cash & Equivalents for 7 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 23.49% to $15.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.5 million, a 23.49% decrease, with the full-year FY2025 number at $15.4 million, down 75.53% from a year prior.
  • Cash & Equivalents was $15.5 million for Q4 2025 at Ibex, down from $22.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $62.7 million in Q2 2024 to a low of $13.0 million in Q1 2025.
  • A 5-year average of $41.3 million and a median of $49.0 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 164.48% in 2021, then tumbled 75.53% in 2025.
  • Ibex's Cash & Equivalents stood at $57.8 million in 2021, then dropped by 15.58% to $48.8 million in 2022, then grew by 0.38% to $49.0 million in 2023, then plummeted by 58.78% to $20.2 million in 2024, then decreased by 23.49% to $15.5 million in 2025.
  • Per Business Quant, the three most recent readings for IBEX's Cash & Equivalents are $15.5 million (Q4 2025), $22.7 million (Q3 2025), and $15.4 million (Q2 2025).